Deepinder Goyal, who is the founder and CEO of Eternal – the parent company overseeing Zomato – has shared the first glimpse of a new and ambitious venture – a specialised health device called ‘Temple.’ The device is being developed to provide accurate, real-time, and continuous monitoring of brain blood flow, thus marking a foray into deep-tech and medical R&D for the Zomato founder.
Goyal took to Instagram to tease the project, sharing an image of the platform with the simple caption, “Getting there.” Sadly, he did not reveal how the product will look or any other related details.
What is Temple all about
The revelation about ‘Temple’ comes with a scientific backing rooted in Goyal’s personal research. The purpose of the device was previously clarified by Goyal on LinkedIn, where he confirmed that Temple is an “experimental device to calculate Brain Flow accurately.”
This new hardware is being developed as a direct tool
This new hardware is being developed as a direct tool for his continued personal research into the “Gravity Ageing Hypothesis,” a conceptual framework Goyal has been exploring related to biological mechanisms and aging. Monitoring brain blood flow continuously and precisely is essential for testing and validating theories related to neurological health and the aging process.
“Been using it for a year, and I’ve been feeling that this could shape into an important wearable the world needs. Brain Flow is already well accepted as a biomarker for ageing, longevity, as well as cognition. So, this device is useful and relevant even if the Gravity Ageing Hypothesis turns out to be wrong,” Goyal previously wrote on LinkedIn.
As far as the promotions related to Temple are concerned, Goyal assures that none of what has been said is a gimmick. “Temple is going to be a small, cute company, if at all. Nothing compared to Eternal. We did not cook up the Gravity Aging Hypothesis to sell Temple. Not my game to lose the trust our customers have in me over a marketing gimmick,” wrote Goyal.
